139 filings
Page 3 of 7
8-K
dk9kx5
13 Apr 22
Regulation FD Disclosure
8:00am
8-K
m1hek46ai7z5m440d7ep
23 Feb 22
Regulation FD Disclosure
12:02pm
8-K
qtjwf38i
8 Feb 22
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:20am
8-K
whltmuh0zmxo9wk2pl6
5 Jan 22
MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia
9:28am
8-K
vojj3lph4esofpyz124
29 Dec 21
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
cx0e6k
3 Dec 21
Regulation FD Disclosure
4:30pm
8-K
ytuc8uj vm6mxs1nid
16 Nov 21
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:25am
8-K
h9v nzr581hb6fce
12 Nov 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:00pm
8-K
kf6f3r
26 Oct 21
Regulation FD Disclosure
11:00am
8-K
skdw6or7
19 Oct 21
Regulation FD Disclosure
10:30am
8-K
417j dfukw
5 Oct 21
MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials
10:00am
8-K
8ljvj
22 Sep 21
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000
12:52pm
8-K
oem4ld
13 Sep 21
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
5:30pm
8-K
h6tg09foqf4
3 Sep 21
Departure of Directors or Certain Officers
4:38pm
8-K
whf4cnk 7z
2 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K/A
lfmp 5ungit
2 Jul 21
Financial Statements and Exhibits
4:00pm
8-K
qve3rmq0
13 May 21
Regulation FD Disclosure
6:20am
8-K
vepbxgq82
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
icbyd4efzpck8m536t
16 Apr 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
8cujkeu2x
19 Mar 21
Entry into a Material Definitive Agreement
5:26pm